Healthcare companies by risk reading
Healthcare companies by risk reading: 1,695 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 21 October 2026.
Composite readings for 14,899 companies, recomputed 21 October 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Genoway ALGEN | 37 | Normal | Healthcare | France | 5 / 6 | $30M |
| Alliance Healthcare Group Limited MIJ.SI | 19 | Contained | Healthcare | Singapore | 5 / 6 | $30M |
| CLOUDR GROUP LTD. H3L | 67 | Stretched | Healthcare | China | 5 / 6 | $30M |
| Doctor Care Anywhere Group PLC DOC.AX | 31 | Normal | Healthcare | United Kingdom | 4 / 6 | $30M |
| biote Corp - Class A BTMD | 44 | Elevated | Healthcare | United States | 6 / 6 | $30M |
| BioStem Technologies, Inc. BSEM | 22 | Normal | Healthcare | United States | 5 / 6 | $29M |
| China Pharma Holdings Inc CPHI | 79 | Stretched | Healthcare | China | 4 / 6 | $29M |
| Nano X Imaging Ltd NNOX | 53 | Elevated | Healthcare | Israel | 4 / 6 | $29M |
| Abingdon Health Plc ABDX | 42 | Elevated | Healthcare | United Kingdom | 5 / 6 | $29M |
| aap Implantate AG AAQ1.DE | 53 | Elevated | Healthcare | Germany | 5 / 6 | $29M |
| Nortech Systems Inc NSYS | 54 | Elevated | Healthcare | United States | 6 / 6 | $29M |
| Rockwell Medical Inc RMTI | 47 | Elevated | Healthcare | United States | 5 / 6 | $29M |
| Linical Co., Ltd. 2183.T | 60 | Stretched | Healthcare | Japan | 5 / 6 | $29M |
| Arts Optical International Holdings Limited 1120.HK | 38 | Normal | Healthcare | Hong Kong | 5 / 6 | $29M |
| Kingworld Medicines Group Limited 1110.HK | 42 | Elevated | Healthcare | China | 5 / 6 | $28M |
| Tycoon Group Holdings Limited 3390.HK | 38 | Normal | Healthcare | Hong Kong | 5 / 6 | $28M |
| IRLAB Therapeutics AB (publ) IRLAB-A | 79 | Stretched | Healthcare | Sweden | 4 / 6 | $28M |
| Kohjin Bio Co., Ltd. 177A.T | 44 | Elevated | Healthcare | Japan | 5 / 6 | $27M |
| Cosmos Health Inc COSM | 62 | Stretched | Healthcare | Greece | 4 / 6 | $27M |
| Vicplas International Ltd 569.SI | 62 | Stretched | Healthcare | Singapore | 4 / 6 | $26M |
| Extrawell Pharmaceutical Holdings Limited 0858.HK | 46 | Elevated | Healthcare | Hong Kong | 5 / 6 | $26M |
| Diagnostic Medical Systems SA ALDMS | 30 | Normal | Healthcare | France | 5 / 6 | $26M |
| Heramed Ltd HMD | 57 | Elevated | Healthcare | Australia | 4 / 6 | $26M |
| Nova Eye Medical Limited EYE.AX | 32 | Normal | Healthcare | Australia | 4 / 6 | $26M |
| Petmed Express Inc PETS | 61 | Stretched | Healthcare | United States | 4 / 6 | $26M |
| internet infinity Inc. 6545.T | 18 | Contained | Healthcare | Japan | 5 / 6 | $26M |
| Implanet SA ALIMP | 48 | Elevated | Healthcare | France | 5 / 6 | $26M |
| Noile-Immune Biotech Inc. 4893.T | 78 | Stretched | Healthcare | Japan | 3 / 6 | $26M |
| DocGo Inc DCGO | 60 | Stretched | Healthcare | United States | 5 / 6 | $26M |
| IGC Pharma Inc IGC | 53 | Elevated | Healthcare | United States | 6 / 6 | $26M |
| genedrive plc GDR | 38 | Normal | Healthcare | United Kingdom | 5 / 6 | $26M |
| Resonance Health Limited RHT.AX | 29 | Normal | Healthcare | Australia | 4 / 6 | $26M |
| Mauna Kea Technologies SAS ALMKT | 61 | Stretched | Healthcare | France | 5 / 6 | $25M |
| Ikonisys SA ALIKO | 60 | Stretched | Healthcare | France | 5 / 6 | $25M |
| I.M.D. International Medical Devices S.p.A. IMD.MI | 34 | Normal | Healthcare | Italy | 5 / 6 | $25M |
| Trajan Group Holdings Ltd TRJ | 32 | Normal | Healthcare | Australia | 4 / 6 | $25M |
| D. Western Therapeutics Institute, Inc. 4576.T | 61 | Stretched | Healthcare | Japan | 5 / 6 | $25M |
| Japan Hospice Holdings Inc. 7061.T | 37 | Normal | Healthcare | Japan | 5 / 6 | $25M |
| Ribomic Inc. 4591.T | 71 | Stretched | Healthcare | Japan | 4 / 6 | $24M |
| Sunwels Co.,Ltd. 9229.T | 46 | Elevated | Healthcare | Japan | 5 / 6 | $24M |
| ABVC BioPharma Inc ABVC | 81 | Acute | Healthcare | United States | 4 / 6 | $24M |
| Rua Life Sciences PLC RUA | 59 | Elevated | Healthcare | United Kingdom | 5 / 6 | $24M |
| Transgenic Group Inc. 2342.T | 39 | Normal | Healthcare | Japan | 5 / 6 | $24M |
| MedRx Co., Ltd 4586.T | 62 | Stretched | Healthcare | Japan | 4 / 6 | $23M |
| teno. Holdings Company Limited 7037.T | 22 | Normal | Healthcare | Japan | 5 / 6 | $23M |
| IM Cannabis Corp IMCC | 40 | Elevated | Healthcare | Canada | 4 / 6 | $23M |
| Ropharma Bras RPH | 28 | Normal | Healthcare | Romania | 5 / 6 | $23M |
| Kontafarma China Holdings Limited 1312.HK | 55 | Elevated | Healthcare | Hong Kong | 5 / 6 | $23M |
| IXICO PLC IXI | 57 | Elevated | Healthcare | United Kingdom | 5 / 6 | $23M |
| Seres Therapeutics Inc MCRB | 69 | Stretched | Healthcare | United States | 4 / 6 | $23M |
| Emyria Limited EMD.AX | 66 | Stretched | Healthcare | Australia | 4 / 6 | $23M |
| AMCO United Holding Limited 0630.HK | 30 | Normal | Healthcare | Hong Kong | 5 / 6 | $23M |
| NanoRepro AG NN6.DE | 39 | Normal | Healthcare | Germany | 4 / 6 | $23M |
| Inspiration Healthcare Group PLC IHC | 40 | Elevated | Healthcare | United Kingdom | 5 / 6 | $22M |
| CleanSpace Holdings Limited CSX.AX | 25 | Normal | Healthcare | Australia | 4 / 6 | $22M |
| Control Bionics Limited CBL.AX | 80 | Acute | Healthcare | Australia | 4 / 6 | $22M |
| Wel-Dish.Incorporated 2901.T | 34 | Normal | Healthcare | Japan | 5 / 6 | $22M |
| HELYX INDUSTRIES HLX.MI | 48 | Elevated | Healthcare | Italy | 5 / 6 | $22M |
| Yestar Healthcare Holdings Company Limited 2393.HK | 42 | Elevated | Healthcare | China | 5 / 6 | $22M |
| TherapeuticsMD Inc TXMD | 69 | Stretched | Healthcare | United States | 4 / 6 | $22M |
| Aytu BioPharma Inc AYTU | 49 | Elevated | Healthcare | United States | 5 / 6 | $22M |
| Radiopharm Theranostics Ltd RAD | 36 | Normal | Healthcare | Australia | 3 / 6 | $22M |
| Picard Medical Inc PMI | 51 | Elevated | Healthcare | United States | 4 / 6 | $22M |
| Vitasora Health Ltd VHL | 56 | Elevated | Healthcare | Australia | 4 / 6 | $21M |
| Kyntra Bio Inc KYNB | 84 | Acute | Healthcare | United States | 4 / 6 | $21M |
| Maat Pharma SA MAAT | 44 | Elevated | Healthcare | France | 5 / 6 | $21M |
| ARTERRA BIOSCIENCE ARBS.MI | 17 | Contained | Healthcare | Italy | 5 / 6 | $21M |
| Medinex Limited OTX.SI | 26 | Normal | Healthcare | Singapore | 5 / 6 | $21M |
| GIMIC Co., Ltd. 475A.T | 37 | Normal | Healthcare | Japan | 4 / 6 | $21M |
| SkinBioTherapeutics PLC SBTX | 32 | Normal | Healthcare | United Kingdom | 5 / 6 | $21M |
| Oxford Biodynamics PLC OBD | 61 | Stretched | Healthcare | United Kingdom | 5 / 6 | $21M |
| InspireMD Inc NSPR | 45 | Elevated | Healthcare | United States | 6 / 6 | $21M |
| Human Metabolome Technologies, Inc. 6090.T | 28 | Normal | Healthcare | Japan | 5 / 6 | $21M |
| Maternus-Kliniken Aktiengesellschaft MAK | 43 | Elevated | Healthcare | Germany | 5 / 6 | $20M |
| BCAL Diagnostics Limited BDX.AX | 63 | Stretched | Healthcare | Australia | 3 / 6 | $20M |
| Microba Life Sciences Limited MAP.AX | 47 | Elevated | Healthcare | Australia | 4 / 6 | $20M |
| Cambridge Cognition Holdings Plc COG | 52 | Elevated | Healthcare | United Kingdom | 5 / 6 | $20M |
| Qinghai Biotech Pharmaceutical Group Limited 0876.HK | 60 | Stretched | Healthcare | Hong Kong | 5 / 6 | $20M |
| FB Care Service Co.,Ltd. 9220.T | 22 | Normal | Healthcare | Japan | 5 / 6 | $20M |
| FARMACOSMO COSMO.MI | 59 | Elevated | Healthcare | Italy | 5 / 6 | $20M |
| Owens & Minor Inc ACH | 56 | Elevated | Healthcare | United States | 4 / 6 | $20M |
| Miahelsa Holdings Corporation 7129.T | 26 | Normal | Healthcare | Japan | 5 / 6 | $20M |
| MAINZ BIOMED B.V. EO 1 4TO | 68 | Stretched | Healthcare | Germany | 4 / 6 | $20M |
| Marker Therapeutics Inc MRKR | 60 | Stretched | Healthcare | United States | 3 / 6 | $19M |
| Optimi Health Corp. OPTH | 56 | Elevated | Healthcare | Canada | 5 / 6 | $19M |
| Pathkey.ai Ltd PKY | 94 | Acute | Healthcare | Australia | 3 / 6 | $19M |
| Platz Co., Ltd. 7813.T | 22 | Normal | Healthcare | Japan | 4 / 6 | $19M |
| Fusion Antibodies plc FAB.L | 40 | Elevated | Healthcare | United Kingdom | 5 / 6 | $19M |
| Lifecare ASA LIFE.OL | 81 | Acute | Healthcare | Norway | 3 / 6 | $19M |
| MRT Inc. 6034.T | 37 | Normal | Healthcare | Japan | 5 / 6 | $19M |
| Beamtree Holdings Limited BMT.AX | 19 | Contained | Healthcare | Australia | 3 / 6 | $19M |
| Gensight Biologics SA SIGHT | 86 | Acute | Healthcare | France | 5 / 6 | $19M |
| Celyad SA CYAD | 65 | Stretched | Healthcare | Belgium | 5 / 6 | $19M |
| MRSO Inc. 5619.T | 52 | Elevated | Healthcare | Japan | 5 / 6 | $18M |
| Neuphoria Therapeutics Inc NEUP | 59 | Elevated | Healthcare | United States | 4 / 6 | $18M |
| Oncosil Medical Ltd OSL | 37 | Normal | Healthcare | Australia | 4 / 6 | $18M |
| Mendell Helium plc MDH.L | 57 | Elevated | Healthcare | United Kingdom | 4 / 6 | $18M |
| Neurotech International Ltd NTI | 78 | Stretched | Healthcare | Australia | 3 / 6 | $18M |
| PROBIOTIX HEALTH LS-05 X90 | 43 | Elevated | Healthcare | United Kingdom | 4 / 6 | $18M |
| AHC Group Inc. 7083.T | 30 | Normal | Healthcare | Japan | 5 / 6 | $18M |
By sector
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.